MX9707683A - Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan. - Google Patents

Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan.

Info

Publication number
MX9707683A
MX9707683A MX9707683A MX9707683A MX9707683A MX 9707683 A MX9707683 A MX 9707683A MX 9707683 A MX9707683 A MX 9707683A MX 9707683 A MX9707683 A MX 9707683A MX 9707683 A MX9707683 A MX 9707683A
Authority
MX
Mexico
Prior art keywords
benazeprilat
valsartan
combination compositions
compositions containing
formula
Prior art date
Application number
MX9707683A
Other languages
English (en)
Spanish (es)
Inventor
Marc De Gasparo
Randy Lee Webb
David Saul Cohen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX9707683A publication Critical patent/MX9707683A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
MX9707683A 1995-04-07 1996-04-02 Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan. MX9707683A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH101295 1995-04-07
PCT/EP1996/001440 WO1996031234A1 (fr) 1995-04-07 1996-04-02 Compositions de combinaison contenant benazeprile ou benazeprilat et valsartane

Publications (1)

Publication Number Publication Date
MX9707683A true MX9707683A (es) 1997-12-31

Family

ID=4200393

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9707683A MX9707683A (es) 1995-04-07 1996-04-02 Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan.

Country Status (15)

Country Link
EP (1) EP0820302A1 (fr)
JP (1) JPH11503139A (fr)
KR (1) KR19980703647A (fr)
CN (1) CN1181019A (fr)
AU (1) AU5399096A (fr)
BR (1) BR9604818A (fr)
CA (1) CA2214143A1 (fr)
CZ (1) CZ313897A3 (fr)
HU (1) HUP9801593A2 (fr)
MX (1) MX9707683A (fr)
NO (1) NO974400D0 (fr)
PL (1) PL322529A1 (fr)
SK (1) SK133897A3 (fr)
TR (1) TR199701121T1 (fr)
WO (1) WO1996031234A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2224451A1 (fr) * 1995-06-30 1997-01-23 Merck & Co., Inc. Procede de traitement de nephropathies a l'aide d'un inhibiteur de l'ace et d'un antagoniste de l'a ii
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
HUP0400475A3 (en) * 2000-04-12 2006-02-28 Novartis Ag Pharmaceutical compositions containing combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups and use thereof
AU2001289672B2 (en) 2000-07-19 2005-12-08 Novartis Ag Valsartan salts
GB0020691D0 (en) * 2000-08-22 2000-10-11 Boehringer Ingelheim Pharma Pharmaceutical combination
PL366419A1 (en) * 2000-08-22 2005-01-24 Boehringer Ingelheim Pharma Bmbh & Co.Kg Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
CZ20031678A3 (cs) * 2000-12-18 2003-10-15 Novartis Ag Terapeutická kombinace amlodipinu a benazeprilu
US6869970B2 (en) * 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100377744C (zh) * 2002-07-05 2008-04-02 安徽省生物医学研究所 一种预测acei类降压药药效的复方药
WO2004019876A2 (fr) * 2002-08-28 2004-03-11 Curis, Inc. Administration conjointe de morphogenes et d'inhibiteurs de conversion de l'enzyme de l'angiotensine pour le traitement de l'insuffisance renale chronique
EP1908469A1 (fr) * 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Antagonistes du récepteur de l'angiotensine II pour traiter des désordres sistémiques des chats
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
WO2010133638A1 (fr) 2009-05-20 2010-11-25 Boehringer Ingelheim Vetmedica Gmbh Solution pharmaceutique buvable de telmisartan
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
EP3099328A1 (fr) * 2014-01-31 2016-12-07 Janssen Pharmaceutica NV Procédés de traitement et de prévention de troubles rénaux et de troubles graisseux du foie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970005839B1 (ko) * 1990-05-11 1997-04-21 화이자 인코포레이티드 상승 치료효과를 얻기 위한 조성물 및 방법
EP0629408A1 (fr) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination d'inhibiteurs ACE et d'antagonistes AII

Also Published As

Publication number Publication date
CN1181019A (zh) 1998-05-06
HUP9801593A2 (hu) 1999-01-28
TR199701121T1 (xx) 1998-03-21
CZ313897A3 (cs) 1998-01-14
EP0820302A1 (fr) 1998-01-28
BR9604818A (pt) 1998-06-09
NO974400L (no) 1997-09-23
JPH11503139A (ja) 1999-03-23
SK133897A3 (en) 1998-02-04
PL322529A1 (en) 1998-02-02
CA2214143A1 (fr) 1996-10-10
KR19980703647A (ko) 1998-12-05
NO974400D0 (no) 1997-09-23
WO1996031234A1 (fr) 1996-10-10
AU5399096A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
MX9707683A (es) Composiciones de combinacion que contienen benazepril o benazeprilat y valsartan.
GEP20053470B (en) N-Heteroaryl-Pyridinesulfonamide Derivatives and Their Use as Endothelin Antagonists
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
GB9914486D0 (en) Medicaments
UA49869C2 (uk) Нафтил-заміщені похідні бензимідазолу, фармацевтична композиція, спосіб лікування (варіанти) та спосіб інгібування людського фактора
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
BG106340A (en) Substituted oxoazaheterocyclyl compounds
BG104177A (en) Amlodipin- and atorvastatin-containing therapeutical combinations
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
MY133473A (en) Haterocyclic glycyl beta-alanine derivatives.
HUP9900773A3 (en) Use of carbazole derivatives for producing pharmaceutical compositions suitable for the treatment of congestive heart failure
BG102259A (en) Compostions with controlled paroxetine release
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
BG103947A (en) Derivatives of 9-oxymerythromycin
IL112622A0 (en) Camptothecin derivatives, their preparation and pharmaceutical compositions containing them
ZA953537B (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
RO118870B1 (ro) Monometansulfonat de acid (e)-alfa-[2-n-butil-1-[(4-carboxifenil)metil]-1h-imidazol-5-il]metilen-2-tiofenpropionic, procedee de preparare şi compoziţii farmaceutice
WO1992019211A3 (fr) Imidazobenzoquinones et composition contenant ces dernieres permettant de prevenir ou de traiter l'hypertension ou l'insuffisance cardiaque
AU4080097A (en) Piperazino derivatives as neurokinin antagonists
WO1999026932A8 (fr) Derives heterocycliques substitues par un groupe amidino et leur utilisation en tant qu'anticoagulants
DE69530123D1 (en) Plättchenaggregationsinhibitoren
CA2219359A1 (fr) Derives hydantoine utilises comme produits intermediaires pour principes actifs pharmaceutiques
MX9708416A (es) Derivados de piperazino como antagonistas de neuroquininas.